Trump Announces Deal to Lower Cost of Fertility Drug for IVF Patients
President Donald Trump announced a new deal with drugmaker EMD Serono to lower the cost of a common fertility medication, part of a broader effort to make in vitro fertilization (IVF) more affordable for American families.
The agreement will reduce the price of Gonal-f, a drug widely used in IVF treatments, through TrumpRx, a forthcoming government website that will allow patients to buy discounted medications directly from manufacturers.
Trump also unveiled new federal guidance that will let employers offer fertility benefits separately from major health insurance plans, similar to how dental or vision coverage is provided. “We want to make it easier for all couples to have babies, raise children, and start the families they have always dreamed about,” Trump said.
The move follows a February executive order aimed at cutting IVF costs and expands on previous deals with pharmaceutical companies to reduce drug prices. This marks a tangible step toward easing the financial burden of fertility care.
Dr. Mehmet Oz, head of the Centers for Medicare and Medicaid Services, welcomed the initiative, saying, “There are going to be a lot of Trump babies. I think that’s probably a good thing.”
Patients and industry experts alike have praised the announcement. Roger Shedlin, CEO of fertility benefits provider WIN, called the move “a step in the right direction,” noting that lowering drug costs could significantly reduce overall IVF expenses.
Corinn O’Brien, a 39-year-old from Alabama who underwent three IVF cycles before having her daughter, said the price cuts “would be huge for families” and that expanded fertility coverage from employers “is progress and much appreciated.”
As discussions around reproductive rights and family planning continue, this initiative underscores a crucial aspect of every child’s right, the right to be born and raised in a family environment that ensures care, love, and security, as recognized under the Convention on the Rights of the Child.
Access to fertility treatment helps uphold this principle by supporting families in their fundamental right to create and nurture life.
